［1］Wang L, Kong L, Wu F, et al. Preventing chronic diseases in China［J］. Lancet, 2005, 366 (9499): 1821-1824.
［2］Mensah GA, Mayosi BM. The 2011 United Nations high-level meeting on non-communicable diseases: the africa agenda calls for a 5-by-5 approach［J］. S Afr Med J, 2012, 103(2):77-79.
［3］Weintraub WS, Daniels SR, Burke LE, et al. Value of primordial and primary prevention for cardiovascular disease: a policy statement from the American Heart Association［J］. Circulation, 2011, 124(8): 967-990.
［4］Wang YL, Liang HY, Gao YH, et al. A functional variant of NEDD4L is associated with obesity and related phenotypes in a Han population of southern China［J］. Int J Mol Sci, 2013, 14(4):7433-7444.
［5］Liang H, Wu X, Chen X, et al. Gender difference in association of NEDD4L gene variants among southern Han Chinese with essential hypertension-a population-based case-control study［J］. Clin Exp Hypertens, 2014, 36(5):309-314.
［6］Liang H, Chen X, Chen Q, et al. The metabolic syndrome among postmenopausal women in rural Canton: prevalence, associated factors, and the optimal obesity and atherogenic indices［J］. PLoS One, 2013, 8(9):e74121.
［7］Gaziano TA, Young CR, Fitzmaurice G, et al. Laboratory-based versus non-laboratory-based method for assessment of cardiovascular disease risk: the NHANES I Follow-up Study cohort［J］. Lancet, 2008, 371(9616):923-931.
［8］Perera FP, Herbstman JB. Emerging technology in molecular epidemiology: what epidemiologists need to know［J］. Epidemiology, 2008,19(2):350-352.
［9］Sanada H, Yatabe J, Midorikawa S, et al. Single-nucleotide polymorphisms for diagnosis of salt-sensitive hypertension［J］. Clin Chem, 2006, 52(3): 352-360.
［10］Felder RA, White MJ, Williams SM, et al. Diagnostic tools for hypertension and salt sensitivity testing［J］. Curr Opin Nephrol Hypertens, 2013, 22(1):65-76.
［11］Varga EA, Sturm AC, Misita CP, et al. Cardiology patient pages. Homocysteine and MTHFR |
